This accredited activity has been designed for pharmacists.
To update pharmacists in hospital and community settings on risk management and treatment strategies for Clostridioides difficile infection (CDI), including recent guidelines on drug- associated risks and pharmacologic management.
Upon completion of this activity, participants should be better able to:
- Compare C. difficile infection (CDI) epidemiology and risks in the hospital and community settings
- Discuss the role of the pharmacist’s intervention in CDI risk management and treatment, including prevention and surveillance
- Review available pharmacotherapies for C. difficile, including latest IDSA/SHEA guideline updates